103 related articles for article (PubMed ID: 21843048)
1. Abnormal histone acetylation and methylation levels in esophageal squamous cell carcinomas.
Chen C; Zhao M; Yin N; He B; Wang B; Yuan Y; Yu F; Hu J; Yin B; Lu Q
Cancer Invest; 2011 Oct; 29(8):548-56. PubMed ID: 21843048
[TBL] [Abstract][Full Text] [Related]
2. Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris.
Zhang P; Su Y; Zhao M; Huang W; Lu Q
Eur J Dermatol; 2011; 21(4):552-7. PubMed ID: 21715244
[TBL] [Abstract][Full Text] [Related]
3. Abnormal histone modification patterns in lupus CD4+ T cells.
Hu N; Qiu X; Luo Y; Yuan J; Li Y; Lei W; Zhang G; Zhou Y; Su Y; Lu Q
J Rheumatol; 2008 May; 35(5):804-10. PubMed ID: 18398941
[TBL] [Abstract][Full Text] [Related]
4. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of histone H3 and H4 post-translational modifications of esophageal squamous cell carcinoma with different invasive capabilities.
Zhang K; Li L; Zhu M; Wang G; Xie J; Zhao Y; Fan E; Xu L; Li E
J Proteomics; 2015 Jan; 112():180-9. PubMed ID: 25234497
[TBL] [Abstract][Full Text] [Related]
6. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
[TBL] [Abstract][Full Text] [Related]
7. Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma.
Toh Y; Yamamoto M; Endo K; Ikeda Y; Baba H; Kohnoe S; Yonemasu H; Hachitanda Y; Okamura T; Sugimachi K
Oncol Rep; 2003; 10(2):333-8. PubMed ID: 12579268
[TBL] [Abstract][Full Text] [Related]
8. Aberrant histone acetylation and methylation levels in woman with endometriosis.
Xiaomeng X; Ming Z; Jiezhi M; Xiaoling F
Arch Gynecol Obstet; 2013 Mar; 287(3):487-94. PubMed ID: 23080547
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation-modulated downregulation of RASSF1A expression is associated with the progression of esophageal cancer.
Mao WM; Li P; Zheng QQ; Wang CC; Ge MH; Hu FJ; Fang XH; Dong ZM; Ling ZQ
Arch Med Res; 2011 Apr; 42(3):182-8. PubMed ID: 21722812
[TBL] [Abstract][Full Text] [Related]
10. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
[TBL] [Abstract][Full Text] [Related]
11. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
12. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract][Full Text] [Related]
13. Aberrant epigenetic modifications in peripheral blood mononuclear cells from patients with pemphigus vulgaris.
Zhao M; Huang W; Zhang Q; Gao F; Wang L; Zhang G; Su Y; Xiao R; Zhang J; Tang M; Cheng W; Tan Y; Lu Q
Br J Dermatol; 2012 Sep; 167(3):523-31. PubMed ID: 22512277
[TBL] [Abstract][Full Text] [Related]
14. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
Mitani Y; Oue N; Hamai Y; Aung PP; Matsumura S; Nakayama H; Kamata N; Yasui W
J Pathol; 2005 Jan; 205(1):65-73. PubMed ID: 15586362
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.
Toh Y; Egashira A; Yamamoto M
Gen Thorac Cardiovasc Surg; 2013 May; 61(5):262-9. PubMed ID: 23529258
[TBL] [Abstract][Full Text] [Related]
16. Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas.
Toh Y; Ohga T; Endo K; Adachi E; Kusumoto H; Haraguchi M; Okamura T; Nicolson GL
Int J Cancer; 2004 Jun; 110(3):362-7. PubMed ID: 15095300
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylation is required for progression through mitosis in tobacco cells.
Li Y; Butenko Y; Grafi G
Plant J; 2005 Feb; 41(3):346-52. PubMed ID: 15659094
[TBL] [Abstract][Full Text] [Related]
19. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
[TBL] [Abstract][Full Text] [Related]
20. Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.
Soejima H; Nakagawachi T; Zhao W; Higashimoto K; Urano T; Matsukura S; Kitajima Y; Takeuchi M; Nakayama M; Oshimura M; Miyazaki K; Joh K; Mukai T
Oncogene; 2004 May; 23(25):4380-8. PubMed ID: 15007390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
